Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
|---|---|
| Enthalten in: |
Journal of the European Academy of Dermatology and Venereology : JEADV - 34(2020), 12 vom: 08. Dez., Seite e770-e772 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Talamonti, M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 14.01.2021 Date Revised 14.01.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/jdv.16841 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313112096 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313112096 | ||
| 003 | DE-627 | ||
| 005 | 20231225145851.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/jdv.16841 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1043.xml |
| 035 | |a (DE-627)NLM313112096 | ||
| 035 | |a (NLM)32735716 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Talamonti, M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.01.2021 | ||
| 500 | |a Date Revised 14.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Multicenter Study | |
| 700 | 1 | |a Galluzzo, M |e verfasserin |4 aut | |
| 700 | 1 | |a Chiricozzi, A |e verfasserin |4 aut | |
| 700 | 1 | |a Quaglino, P |e verfasserin |4 aut | |
| 700 | 1 | |a Fabbrocini, G |e verfasserin |4 aut | |
| 700 | 1 | |a Gisondi, P |e verfasserin |4 aut | |
| 700 | 1 | |a Marzano, A V |e verfasserin |4 aut | |
| 700 | 1 | |a Potenza, C |e verfasserin |4 aut | |
| 700 | 1 | |a Conti, A |e verfasserin |4 aut | |
| 700 | 1 | |a Parodi, A |e verfasserin |4 aut | |
| 700 | 1 | |a Belloni Fortina, A |e verfasserin |4 aut | |
| 700 | 1 | |a Bardazzi, F |e verfasserin |4 aut | |
| 700 | 1 | |a Argenziano, G |e verfasserin |4 aut | |
| 700 | 1 | |a Rongioletti, F |e verfasserin |4 aut | |
| 700 | 1 | |a Stingeni, L |e verfasserin |4 aut | |
| 700 | 1 | |a Micali, G |e verfasserin |4 aut | |
| 700 | 1 | |a Loconsole, F |e verfasserin |4 aut | |
| 700 | 1 | |a Venturini, M |e verfasserin |4 aut | |
| 700 | 1 | |a Bongiorno, M R |e verfasserin |4 aut | |
| 700 | 1 | |a Feliciani, C |e verfasserin |4 aut | |
| 700 | 1 | |a Rubegni, P |e verfasserin |4 aut | |
| 700 | 1 | |a Amerio, P |e verfasserin |4 aut | |
| 700 | 1 | |a Fargnoli, M C |e verfasserin |4 aut | |
| 700 | 1 | |a Pigatto, P |e verfasserin |4 aut | |
| 700 | 1 | |a Savoia, P |e verfasserin |4 aut | |
| 700 | 1 | |a Nisticò, S P |e verfasserin |4 aut | |
| 700 | 1 | |a Giustini, S |e verfasserin |4 aut | |
| 700 | 1 | |a Carugno, A |e verfasserin |4 aut | |
| 700 | 1 | |a Cannavò, S P |e verfasserin |4 aut | |
| 700 | 1 | |a Rech, G |e verfasserin |4 aut | |
| 700 | 1 | |a Prignano, F |e verfasserin |4 aut | |
| 700 | 1 | |a Offidani, A |e verfasserin |4 aut | |
| 700 | 1 | |a Lombardo, M |e verfasserin |4 aut | |
| 700 | 1 | |a Zalaudek, I |e verfasserin |4 aut | |
| 700 | 1 | |a Bianchi, L |e verfasserin |4 aut | |
| 700 | 1 | |a Peris, K |e verfasserin |4 aut | |
| 700 | 0 | |a PSO-BIO-COVID study group |e verfasserin |4 aut | |
| 700 | 1 | |a Balestri, R |e investigator |4 oth | |
| 700 | 1 | |a Bernardini, N |e investigator |4 oth | |
| 700 | 1 | |a Botti, E |e investigator |4 oth | |
| 700 | 1 | |a Burlando, M |e investigator |4 oth | |
| 700 | 1 | |a Caldarola, G |e investigator |4 oth | |
| 700 | 1 | |a Cattaneo, A |e investigator |4 oth | |
| 700 | 1 | |a Dapavo, P |e investigator |4 oth | |
| 700 | 1 | |a Dastoli, S |e investigator |4 oth | |
| 700 | 1 | |a De Simone, C |e investigator |4 oth | |
| 700 | 1 | |a Di Nuzzo, S |e investigator |4 oth | |
| 700 | 1 | |a Diotallevi, F |e investigator |4 oth | |
| 700 | 1 | |a Fierro, M T |e investigator |4 oth | |
| 700 | 1 | |a Fidanza, R |e investigator |4 oth | |
| 700 | 1 | |a Foti, C |e investigator |4 oth | |
| 700 | 1 | |a Gambini, D M |e investigator |4 oth | |
| 700 | 1 | |a Gambardella, A |e investigator |4 oth | |
| 700 | 1 | |a Girolomoni, G |e investigator |4 oth | |
| 700 | 1 | |a Guarneri, C |e investigator |4 oth | |
| 700 | 1 | |a Gualdi, G |e investigator |4 oth | |
| 700 | 1 | |a Hansel, K |e investigator |4 oth | |
| 700 | 1 | |a Megna, M |e investigator |4 oth | |
| 700 | 1 | |a Mugheddu, C |e investigator |4 oth | |
| 700 | 1 | |a Musumeci, M L |e investigator |4 oth | |
| 700 | 1 | |a Patrizi, A |e investigator |4 oth | |
| 700 | 1 | |a Pellacani, G |e investigator |4 oth | |
| 700 | 1 | |a Piaserico, S |e investigator |4 oth | |
| 700 | 1 | |a Richetta, A G |e investigator |4 oth | |
| 700 | 1 | |a Rosi, E |e investigator |4 oth | |
| 700 | 1 | |a Rossi, M T |e investigator |4 oth | |
| 700 | 1 | |a Sacchelli, L |e investigator |4 oth | |
| 700 | 1 | |a Tiberio, R |e investigator |4 oth | |
| 700 | 1 | |a Tilotta, G |e investigator |4 oth | |
| 700 | 1 | |a Trovato, E |e investigator |4 oth | |
| 700 | 1 | |a Vezzoni, R |e investigator |4 oth | |
| 700 | 1 | |a Zangrilli, A |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the European Academy of Dermatology and Venereology : JEADV |d 1997 |g 34(2020), 12 vom: 08. Dez., Seite e770-e772 |w (DE-627)NLM091705932 |x 1468-3083 |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2020 |g number:12 |g day:08 |g month:12 |g pages:e770-e772 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/jdv.16841 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 34 |j 2020 |e 12 |b 08 |c 12 |h e770-e772 | ||